Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of IX-01 in Healthy Males
NCT02962531Phase 1Completed
- Sponsor
- Ixchelsis
- Start
- Nov 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cligosiban in premature ejaculation (PE) (3 arms), sponsored by Ixchelsis. Primary endpoints: Peak Plasma Concentration, Time to Peak Plasma Concentration and 3 more. Started Nov 2016; status: completed.
02
Drugs
cligosiban
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT02962531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962531.